Invention Grant
- Patent Title: Pyridazine derivatives as RORc modulators
-
Application No.: US16398795Application Date: 2019-04-30
-
Publication No.: US11008312B2Publication Date: 2021-05-18
- Inventor: Sarah M. Bronner , James J. Crawford , Andrew Cridland , Patrick Cyr , Benjamin Fauber , Emanuela Gancia , Alberto Gobbi , Christopher Hurley , Jonathan Killen , Wendy Lee , Olivier Rene , Monique Bodil Van Niel , Stuart Ward , Paul Winship , Jason Zbieg
- Applicant: Genentech, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agent Brian L. Buckwalter
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D403/14 ; C07D405/14 ; C07D409/14 ; C07D401/14
Abstract:
Compounds of formula I: or pharmaceutical salts thereof, wherein m, n, p, q A, B, R1, R2, R3, R4, R5, R6 and R7 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.
Public/Granted literature
- US20190263794A1 PYRIDAZINE DERIVATIVES AS RORc MODULATORS Public/Granted day:2019-08-29
Information query
